nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—stomach cancer	0.149	1	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—stomach cancer	0.109	0.189	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—stomach cancer	0.0768	0.132	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—stomach cancer	0.0594	0.102	CbGbCtD
Levothyroxine—ABCB1—Mitomycin—stomach cancer	0.0527	0.0909	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—stomach cancer	0.0472	0.0814	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—stomach cancer	0.0429	0.074	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—stomach cancer	0.0265	0.0457	CbGbCtD
Levothyroxine—ALB—Irinotecan—stomach cancer	0.0258	0.0446	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—stomach cancer	0.025	0.0431	CbGbCtD
Levothyroxine—ALB—Fluorouracil—stomach cancer	0.0248	0.0428	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—stomach cancer	0.0192	0.0331	CbGbCtD
Levothyroxine—ALB—Methotrexate—stomach cancer	0.0137	0.0236	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—stomach cancer	0.0135	0.0233	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—stomach cancer	0.0099	0.0171	CbGbCtD
Levothyroxine—CYP3A4—Irinotecan—stomach cancer	0.0081	0.014	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—stomach cancer	0.00738	0.0127	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—stomach cancer	0.00715	0.0123	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—stomach cancer	0.00593	0.0102	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—stomach cancer	0.00442	0.00763	CbGbCtD
Levothyroxine—SERPINA7—hematopoietic system—stomach cancer	0.00367	0.0542	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—stomach cancer	0.00235	0.0347	CbGeAlD
Levothyroxine—SERPINA7—endocrine gland—stomach cancer	0.00211	0.0311	CbGeAlD
Levothyroxine—SERPINA7—liver—stomach cancer	0.0019	0.0281	CbGeAlD
Levothyroxine—ALB—gall bladder—stomach cancer	0.0019	0.0281	CbGeAlD
Levothyroxine—SLC7A5—hematopoietic system—stomach cancer	0.00173	0.0255	CbGeAlD
Levothyroxine—TTR—hematopoietic system—stomach cancer	0.00168	0.0249	CbGeAlD
Levothyroxine—SLC7A5—epithelium—stomach cancer	0.00158	0.0234	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—stomach cancer	0.00152	0.0225	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—stomach cancer	0.00151	0.0224	CbGeAlD
Levothyroxine—SLC7A5—pancreas—stomach cancer	0.00141	0.0208	CbGeAlD
Levothyroxine—TTR—pancreas—stomach cancer	0.00137	0.0203	CbGeAlD
Levothyroxine—SLCO1B1—hematopoietic system—stomach cancer	0.00133	0.0196	CbGeAlD
Levothyroxine—SLCO1B3—endocrine gland—stomach cancer	0.00132	0.0195	CbGeAlD
Levothyroxine—THRB—endocrine gland—stomach cancer	0.0013	0.0192	CbGeAlD
Levothyroxine—THRA—endocrine gland—stomach cancer	0.0013	0.0192	CbGeAlD
Levothyroxine—SLCO4A1—pancreas—stomach cancer	0.00123	0.0182	CbGeAlD
Levothyroxine—SLCO4C1—liver—stomach cancer	0.00122	0.0181	CbGeAlD
Levothyroxine—SLC7A5—lymphoid tissue—stomach cancer	0.00122	0.018	CbGeAlD
Levothyroxine—SLC7A5—digestive system—stomach cancer	0.0012	0.0178	CbGeAlD
Levothyroxine—SLCO1B3—liver—stomach cancer	0.00119	0.0176	CbGeAlD
Levothyroxine—TTR—lymphoid tissue—stomach cancer	0.00119	0.0175	CbGeAlD
Levothyroxine—SLC16A2—endocrine gland—stomach cancer	0.00118	0.0174	CbGeAlD
Levothyroxine—THRB—liver—stomach cancer	0.00117	0.0173	CbGeAlD
Levothyroxine—THRA—liver—stomach cancer	0.00117	0.0173	CbGeAlD
Levothyroxine—TTR—digestive system—stomach cancer	0.00117	0.0173	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—stomach cancer	0.00111	0.0164	CbGeAlD
Levothyroxine—SLCO1C1—endocrine gland—stomach cancer	0.00108	0.016	CbGeAlD
Levothyroxine—SLCO1A2—hematopoietic system—stomach cancer	0.00108	0.016	CbGeAlD
Levothyroxine—TTR—bone marrow—stomach cancer	0.00108	0.016	CbGeAlD
Levothyroxine—SLC16A2—liver—stomach cancer	0.00106	0.0157	CbGeAlD
Levothyroxine—SLCO4A1—digestive system—stomach cancer	0.00105	0.0155	CbGeAlD
Levothyroxine—SLC7A5—endocrine gland—stomach cancer	0.000993	0.0147	CbGeAlD
Levothyroxine—TTR—endocrine gland—stomach cancer	0.000968	0.0143	CbGeAlD
Levothyroxine—SLCO1B1—digestive system—stomach cancer	0.000924	0.0136	CbGeAlD
Levothyroxine—THRB—lymph node—stomach cancer	0.0009	0.0133	CbGeAlD
Levothyroxine—THRA—lymph node—stomach cancer	0.0009	0.0133	CbGeAlD
Levothyroxine—SLC7A5—liver—stomach cancer	0.000896	0.0132	CbGeAlD
Levothyroxine—TTR—liver—stomach cancer	0.000872	0.0129	CbGeAlD
Levothyroxine—SLCO4A1—endocrine gland—stomach cancer	0.000867	0.0128	CbGeAlD
Levothyroxine—SLC16A2—lymph node—stomach cancer	0.000815	0.012	CbGeAlD
Levothyroxine—SLCO4A1—liver—stomach cancer	0.000782	0.0116	CbGeAlD
Levothyroxine—SLCO1B1—endocrine gland—stomach cancer	0.000763	0.0113	CbGeAlD
Levothyroxine—CYP2C8—hematopoietic system—stomach cancer	0.000755	0.0112	CbGeAlD
Levothyroxine—SLCO1A2—digestive system—stomach cancer	0.000752	0.0111	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—stomach cancer	0.000748	0.0111	CbGeAlD
Levothyroxine—SLCO1B1—liver—stomach cancer	0.000688	0.0102	CbGeAlD
Levothyroxine—SLC7A5—lymph node—stomach cancer	0.000687	0.0101	CbGeAlD
Levothyroxine—ABCB1—blood vessel—stomach cancer	0.00068	0.01	CbGeAlD
Levothyroxine—SLCO1A2—endocrine gland—stomach cancer	0.000621	0.00918	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—stomach cancer	0.0006	0.00886	CbGeAlD
Levothyroxine—Dermatitis—Floxuridine—stomach cancer	0.000566	0.0066	CcSEcCtD
Levothyroxine—Headache—Floxuridine—stomach cancer	0.000563	0.00656	CcSEcCtD
Levothyroxine—SLCO1A2—liver—stomach cancer	0.00056	0.00828	CbGeAlD
Levothyroxine—Body temperature increased—Mitomycin—stomach cancer	0.000557	0.0065	CcSEcCtD
Levothyroxine—ALB—liver—stomach cancer	0.000557	0.00823	CbGeAlD
Levothyroxine—Nausea—Floxuridine—stomach cancer	0.000534	0.00622	CcSEcCtD
Levothyroxine—Muscular weakness—Fluorouracil—stomach cancer	0.000526	0.00614	CcSEcCtD
Levothyroxine—Angina pectoris—Irinotecan—stomach cancer	0.000525	0.00612	CcSEcCtD
Levothyroxine—Sweating increased—Irinotecan—stomach cancer	0.000525	0.00612	CcSEcCtD
Levothyroxine—Dysphagia—Fluorouracil—stomach cancer	0.000516	0.00601	CcSEcCtD
Levothyroxine—CYP3A4—hematopoietic system—stomach cancer	0.000512	0.00756	CbGeAlD
Levothyroxine—Asthenia—Mitomycin—stomach cancer	0.000506	0.0059	CcSEcCtD
Levothyroxine—Angina pectoris—Fluorouracil—stomach cancer	0.000502	0.00586	CcSEcCtD
Levothyroxine—Weight decreased—Irinotecan—stomach cancer	0.000487	0.00568	CcSEcCtD
Levothyroxine—Diarrhoea—Mitomycin—stomach cancer	0.000482	0.00562	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Docetaxel—stomach cancer	0.000475	0.00554	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Irinotecan—stomach cancer	0.000473	0.00552	CcSEcCtD
Levothyroxine—Myocardial infarction—Irinotecan—stomach cancer	0.000471	0.00549	CcSEcCtD
Levothyroxine—Sweating—Irinotecan—stomach cancer	0.00046	0.00537	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Fluorouracil—stomach cancer	0.000453	0.00528	CcSEcCtD
Levothyroxine—Myocardial infarction—Fluorouracil—stomach cancer	0.000451	0.00525	CcSEcCtD
Levothyroxine—Vomiting—Mitomycin—stomach cancer	0.000448	0.00523	CcSEcCtD
Levothyroxine—Rash—Mitomycin—stomach cancer	0.000445	0.00518	CcSEcCtD
Levothyroxine—Dermatitis—Mitomycin—stomach cancer	0.000444	0.00518	CcSEcCtD
Levothyroxine—Increased appetite—Capecitabine—stomach cancer	0.000444	0.00517	CcSEcCtD
Levothyroxine—Headache—Mitomycin—stomach cancer	0.000442	0.00515	CcSEcCtD
Levothyroxine—Cardiac failure—Docetaxel—stomach cancer	0.000441	0.00514	CcSEcCtD
Levothyroxine—CYP2C8—endocrine gland—stomach cancer	0.000434	0.00641	CbGeAlD
Levothyroxine—Cardiac failure—Capecitabine—stomach cancer	0.000427	0.00498	CcSEcCtD
Levothyroxine—ALB—lymph node—stomach cancer	0.000427	0.00631	CbGeAlD
Levothyroxine—Nausea—Mitomycin—stomach cancer	0.000419	0.00488	CcSEcCtD
Levothyroxine—Dehydration—Docetaxel—stomach cancer	0.000401	0.00467	CcSEcCtD
Levothyroxine—Flushing—Irinotecan—stomach cancer	0.0004	0.00466	CcSEcCtD
Levothyroxine—Irritability—Capecitabine—stomach cancer	0.000398	0.00464	CcSEcCtD
Levothyroxine—Cardiac arrest—Capecitabine—stomach cancer	0.000397	0.00462	CcSEcCtD
Levothyroxine—Mood swings—Capecitabine—stomach cancer	0.000395	0.00461	CcSEcCtD
Levothyroxine—CYP2C8—liver—stomach cancer	0.000391	0.00578	CbGeAlD
Levothyroxine—Coma—Methotrexate—stomach cancer	0.000391	0.00456	CcSEcCtD
Levothyroxine—Dehydration—Capecitabine—stomach cancer	0.000388	0.00452	CcSEcCtD
Levothyroxine—Arrhythmia—Irinotecan—stomach cancer	0.000385	0.00449	CcSEcCtD
Levothyroxine—Alopecia—Irinotecan—stomach cancer	0.000381	0.00444	CcSEcCtD
Levothyroxine—Dysphagia—Docetaxel—stomach cancer	0.000372	0.00434	CcSEcCtD
Levothyroxine—Arrhythmia—Fluorouracil—stomach cancer	0.000369	0.0043	CcSEcCtD
Levothyroxine—Muscular weakness—Capecitabine—stomach cancer	0.000368	0.00429	CcSEcCtD
Levothyroxine—Coma—Epirubicin—stomach cancer	0.000366	0.00426	CcSEcCtD
Levothyroxine—Alopecia—Fluorouracil—stomach cancer	0.000365	0.00425	CcSEcCtD
Levothyroxine—Angina pectoris—Docetaxel—stomach cancer	0.000363	0.00423	CcSEcCtD
Levothyroxine—ABCB1—hematopoietic system—stomach cancer	0.000362	0.00535	CbGeAlD
Levothyroxine—Dysphagia—Capecitabine—stomach cancer	0.00036	0.0042	CcSEcCtD
Levothyroxine—CYP3A4—digestive system—stomach cancer	0.000356	0.00526	CbGeAlD
Levothyroxine—Sweating increased—Capecitabine—stomach cancer	0.000351	0.00409	CcSEcCtD
Levothyroxine—Angina pectoris—Capecitabine—stomach cancer	0.000351	0.00409	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—stomach cancer	0.000338	0.00394	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—stomach cancer	0.000337	0.00393	CcSEcCtD
Levothyroxine—ABCB1—epithelium—stomach cancer	0.000331	0.00489	CbGeAlD
Levothyroxine—Acute coronary syndrome—Docetaxel—stomach cancer	0.000327	0.00381	CcSEcCtD
Levothyroxine—Weight decreased—Capecitabine—stomach cancer	0.000326	0.0038	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—stomach cancer	0.000325	0.00379	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—stomach cancer	0.00032	0.00373	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Capecitabine—stomach cancer	0.000317	0.00369	CcSEcCtD
Levothyroxine—Myocardial infarction—Capecitabine—stomach cancer	0.000315	0.00367	CcSEcCtD
Levothyroxine—Convulsion—Fluorouracil—stomach cancer	0.000311	0.00363	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—stomach cancer	0.000309	0.0036	CcSEcCtD
Levothyroxine—Confusional state—Irinotecan—stomach cancer	0.000309	0.0036	CcSEcCtD
Levothyroxine—Shock—Irinotecan—stomach cancer	0.000301	0.00351	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—stomach cancer	0.000298	0.00347	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—stomach cancer	0.000298	0.00347	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000296	0.00346	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—stomach cancer	0.000296	0.00345	CcSEcCtD
Levothyroxine—Hyperhidrosis—Irinotecan—stomach cancer	0.000296	0.00345	CcSEcCtD
Levothyroxine—Confusional state—Fluorouracil—stomach cancer	0.000296	0.00345	CcSEcCtD
Levothyroxine—ABCB1—pancreas—stomach cancer	0.000295	0.00436	CbGeAlD
Levothyroxine—Mood swings—Methotrexate—stomach cancer	0.000294	0.00343	CcSEcCtD
Levothyroxine—CYP3A4—endocrine gland—stomach cancer	0.000294	0.00434	CbGeAlD
Levothyroxine—Tachycardia—Fluorouracil—stomach cancer	0.000286	0.00334	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—stomach cancer	0.000286	0.00334	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—stomach cancer	0.000286	0.00333	CcSEcCtD
Levothyroxine—Insomnia—Irinotecan—stomach cancer	0.000277	0.00323	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—stomach cancer	0.000277	0.00322	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—stomach cancer	0.000276	0.00322	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—stomach cancer	0.000275	0.00321	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—stomach cancer	0.000275	0.00321	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—stomach cancer	0.000275	0.00321	CcSEcCtD
Levothyroxine—Dyspnoea—Irinotecan—stomach cancer	0.000273	0.00318	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—stomach cancer	0.00027	0.00315	CcSEcCtD
Levothyroxine—Flushing—Capecitabine—stomach cancer	0.000268	0.00312	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000267	0.00312	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—stomach cancer	0.000266	0.0031	CcSEcCtD
Levothyroxine—Insomnia—Fluorouracil—stomach cancer	0.000265	0.00309	CcSEcCtD
Levothyroxine—CYP3A4—liver—stomach cancer	0.000265	0.00392	CbGeAlD
Levothyroxine—Affect lability—Doxorubicin—stomach cancer	0.000265	0.00308	CcSEcCtD
Levothyroxine—Fatigue—Irinotecan—stomach cancer	0.000264	0.00308	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—stomach cancer	0.000263	0.00307	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—stomach cancer	0.000262	0.00305	CcSEcCtD
Levothyroxine—Arrhythmia—Capecitabine—stomach cancer	0.000258	0.003	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—stomach cancer	0.000256	0.00299	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—stomach cancer	0.000256	0.00298	CcSEcCtD
Levothyroxine—ABCB1—lymphoid tissue—stomach cancer	0.000255	0.00377	CbGeAlD
Levothyroxine—Alopecia—Capecitabine—stomach cancer	0.000255	0.00297	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—stomach cancer	0.000255	0.00297	CcSEcCtD
Levothyroxine—Feeling abnormal—Irinotecan—stomach cancer	0.000252	0.00294	CcSEcCtD
Levothyroxine—ABCB1—digestive system—stomach cancer	0.000252	0.00372	CbGeAlD
Levothyroxine—Dysphagia—Epirubicin—stomach cancer	0.000251	0.00293	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Irinotecan—stomach cancer	0.00025	0.00292	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—stomach cancer	0.00025	0.00291	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—stomach cancer	0.000245	0.00285	CcSEcCtD
Levothyroxine—Abdominal pain—Irinotecan—stomach cancer	0.000242	0.00282	CcSEcCtD
Levothyroxine—Body temperature increased—Irinotecan—stomach cancer	0.000242	0.00282	CcSEcCtD
Levothyroxine—Feeling abnormal—Fluorouracil—stomach cancer	0.000242	0.00282	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—stomach cancer	0.000237	0.00276	CcSEcCtD
Levothyroxine—Tremor—Capecitabine—stomach cancer	0.000235	0.00274	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—stomach cancer	0.000233	0.00272	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—stomach cancer	0.000232	0.00271	CcSEcCtD
Levothyroxine—ABCB1—bone marrow—stomach cancer	0.000232	0.00343	CbGeAlD
Levothyroxine—Body temperature increased—Fluorouracil—stomach cancer	0.000232	0.0027	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—stomach cancer	0.000229	0.00267	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—stomach cancer	0.000229	0.00267	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—stomach cancer	0.000227	0.00265	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—stomach cancer	0.000226	0.00264	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—stomach cancer	0.000225	0.00262	CcSEcCtD
Levothyroxine—Palpitations—Capecitabine—stomach cancer	0.000222	0.00259	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—stomach cancer	0.000221	0.00257	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—stomach cancer	0.00022	0.00256	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—stomach cancer	0.000215	0.0025	CcSEcCtD
Levothyroxine—Arthralgia—Capecitabine—stomach cancer	0.000214	0.00249	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—stomach cancer	0.000213	0.00249	CcSEcCtD
Levothyroxine—Anxiety—Capecitabine—stomach cancer	0.000213	0.00248	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—stomach cancer	0.00021	0.00245	CcSEcCtD
Levothyroxine—Diarrhoea—Irinotecan—stomach cancer	0.00021	0.00244	CcSEcCtD
Levothyroxine—Shock—Docetaxel—stomach cancer	0.000208	0.00243	CcSEcCtD
Levothyroxine—ABCB1—endocrine gland—stomach cancer	0.000208	0.00307	CbGeAlD
Levothyroxine—Pruritus—Fluorouracil—stomach cancer	0.000208	0.00242	CcSEcCtD
Levothyroxine—Confusional state—Capecitabine—stomach cancer	0.000207	0.00241	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—stomach cancer	0.000207	0.00241	CcSEcCtD
Levothyroxine—Shock—Capecitabine—stomach cancer	0.000202	0.00235	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—stomach cancer	0.000201	0.00234	CcSEcCtD
Levothyroxine—Tachycardia—Capecitabine—stomach cancer	0.0002	0.00233	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—stomach cancer	0.000199	0.00232	CcSEcCtD
Levothyroxine—Hyperhidrosis—Capecitabine—stomach cancer	0.000198	0.00231	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—stomach cancer	0.000195	0.00227	CcSEcCtD
Levothyroxine—Rash—Irinotecan—stomach cancer	0.000193	0.00225	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—stomach cancer	0.000193	0.00225	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000193	0.00225	CcSEcCtD
Levothyroxine—Headache—Irinotecan—stomach cancer	0.000192	0.00224	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—stomach cancer	0.000191	0.00223	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—stomach cancer	0.00019	0.00221	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—stomach cancer	0.000189	0.0022	CcSEcCtD
Levothyroxine—ABCB1—liver—stomach cancer	0.000188	0.00277	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000187	0.00218	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—stomach cancer	0.000187	0.00217	CcSEcCtD
Levothyroxine—Vomiting—Fluorouracil—stomach cancer	0.000186	0.00217	CcSEcCtD
Levothyroxine—Insomnia—Capecitabine—stomach cancer	0.000185	0.00216	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—stomach cancer	0.000185	0.00216	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—stomach cancer	0.000185	0.00215	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—stomach cancer	0.000184	0.00214	CcSEcCtD
Levothyroxine—Dyspnoea—Capecitabine—stomach cancer	0.000183	0.00213	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—stomach cancer	0.000183	0.00213	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—stomach cancer	0.000182	0.00212	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—stomach cancer	0.00018	0.00209	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—stomach cancer	0.000178	0.00207	CcSEcCtD
Levothyroxine—Fatigue—Capecitabine—stomach cancer	0.000177	0.00206	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—stomach cancer	0.000174	0.00203	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—stomach cancer	0.000174	0.00203	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000173	0.00202	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—stomach cancer	0.000173	0.00201	CcSEcCtD
Levothyroxine—Tension—Epirubicin—stomach cancer	0.000172	0.002	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—stomach cancer	0.00017	0.00198	CcSEcCtD
Levothyroxine—Feeling abnormal—Capecitabine—stomach cancer	0.000169	0.00197	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000168	0.00195	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—stomach cancer	0.000167	0.00195	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—stomach cancer	0.000167	0.00195	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—stomach cancer	0.000166	0.00194	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—stomach cancer	0.000164	0.00192	CcSEcCtD
Levothyroxine—Urticaria—Capecitabine—stomach cancer	0.000163	0.0019	CcSEcCtD
Levothyroxine—Body temperature increased—Capecitabine—stomach cancer	0.000162	0.00189	CcSEcCtD
Levothyroxine—Abdominal pain—Capecitabine—stomach cancer	0.000162	0.00189	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—stomach cancer	0.000162	0.00189	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—stomach cancer	0.000161	0.00187	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—stomach cancer	0.000159	0.00186	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—stomach cancer	0.000159	0.00185	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—stomach cancer	0.000157	0.00183	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—stomach cancer	0.000155	0.0018	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—stomach cancer	0.000154	0.00179	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—stomach cancer	0.000152	0.00177	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—stomach cancer	0.000152	0.00177	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—stomach cancer	0.00015	0.00175	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—stomach cancer	0.000149	0.00174	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—stomach cancer	0.000149	0.00173	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—stomach cancer	0.000148	0.00173	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—stomach cancer	0.000148	0.00172	CcSEcCtD
Levothyroxine—Asthenia—Capecitabine—stomach cancer	0.000147	0.00171	CcSEcCtD
Levothyroxine—Pruritus—Capecitabine—stomach cancer	0.000145	0.00169	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—stomach cancer	0.000145	0.00169	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—stomach cancer	0.000144	0.00168	CcSEcCtD
Levothyroxine—ABCB1—lymph node—stomach cancer	0.000144	0.00213	CbGeAlD
Levothyroxine—Palpitations—Doxorubicin—stomach cancer	0.000143	0.00167	CcSEcCtD
Levothyroxine—Shock—Epirubicin—stomach cancer	0.00014	0.00164	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—stomach cancer	0.00014	0.00164	CcSEcCtD
Levothyroxine—Diarrhoea—Capecitabine—stomach cancer	0.00014	0.00163	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—stomach cancer	0.000139	0.00162	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000139	0.00162	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—stomach cancer	0.000138	0.00161	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—stomach cancer	0.000138	0.00161	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—stomach cancer	0.000138	0.00161	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—stomach cancer	0.000137	0.0016	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—stomach cancer	0.000136	0.00159	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—stomach cancer	0.000135	0.00157	CcSEcCtD
Levothyroxine—Rash—Docetaxel—stomach cancer	0.000133	0.00156	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—stomach cancer	0.000133	0.00155	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—stomach cancer	0.000133	0.00155	CcSEcCtD
Levothyroxine—Headache—Docetaxel—stomach cancer	0.000133	0.00155	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—stomach cancer	0.000132	0.00153	CcSEcCtD
Levothyroxine—Vomiting—Capecitabine—stomach cancer	0.00013	0.00152	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00013	0.00152	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—stomach cancer	0.00013	0.00152	CcSEcCtD
Levothyroxine—Rash—Capecitabine—stomach cancer	0.000129	0.00151	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—stomach cancer	0.000129	0.00151	CcSEcCtD
Levothyroxine—Dermatitis—Capecitabine—stomach cancer	0.000129	0.00151	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—stomach cancer	0.000129	0.0015	CcSEcCtD
Levothyroxine—Headache—Capecitabine—stomach cancer	0.000128	0.0015	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000128	0.00149	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—stomach cancer	0.000127	0.00148	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—stomach cancer	0.000126	0.00147	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—stomach cancer	0.000126	0.00147	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000125	0.00145	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—stomach cancer	0.000123	0.00144	CcSEcCtD
Levothyroxine—Nausea—Capecitabine—stomach cancer	0.000122	0.00142	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—stomach cancer	0.000121	0.00141	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—stomach cancer	0.000121	0.00141	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—stomach cancer	0.000121	0.00141	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00012	0.0014	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—stomach cancer	0.00012	0.00139	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—stomach cancer	0.000118	0.00137	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—stomach cancer	0.000118	0.00137	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000117	0.00136	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—stomach cancer	0.000114	0.00133	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—stomach cancer	0.000113	0.00132	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—stomach cancer	0.000113	0.00132	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—stomach cancer	0.000113	0.00132	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—stomach cancer	0.000109	0.00128	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—stomach cancer	0.000109	0.00127	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000108	0.00126	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—stomach cancer	0.000108	0.00126	CcSEcCtD
Levothyroxine—Liotrix—ALB—stomach cancer	0.000106	0.578	CrCbGaD
Levothyroxine—Urticaria—Doxorubicin—stomach cancer	0.000105	0.00122	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—stomach cancer	0.000104	0.00122	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—stomach cancer	0.000104	0.00122	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—stomach cancer	0.000104	0.00122	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—stomach cancer	0.000102	0.00119	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—stomach cancer	0.000101	0.00118	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—stomach cancer	9.77e-05	0.00114	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—stomach cancer	9.7e-05	0.00113	CcSEcCtD
Levothyroxine—Rash—Methotrexate—stomach cancer	9.62e-05	0.00112	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—stomach cancer	9.61e-05	0.00112	CcSEcCtD
Levothyroxine—Headache—Methotrexate—stomach cancer	9.56e-05	0.00111	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—stomach cancer	9.48e-05	0.0011	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—stomach cancer	9.35e-05	0.00109	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—stomach cancer	9.08e-05	0.00106	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—stomach cancer	9.06e-05	0.00106	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—stomach cancer	9.04e-05	0.00105	CcSEcCtD
Levothyroxine—Rash—Epirubicin—stomach cancer	9e-05	0.00105	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—stomach cancer	9e-05	0.00105	CcSEcCtD
Levothyroxine—Headache—Epirubicin—stomach cancer	8.95e-05	0.00104	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—stomach cancer	8.48e-05	0.000989	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—stomach cancer	8.4e-05	0.000979	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—stomach cancer	8.33e-05	0.000971	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—stomach cancer	8.32e-05	0.00097	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—stomach cancer	8.28e-05	0.000965	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—stomach cancer	7.85e-05	0.000915	CcSEcCtD
Levothyroxine—Liothyronine—ALB—stomach cancer	7.75e-05	0.422	CrCbGaD
Levothyroxine—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.37e-05	0.000116	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.36e-05	0.000115	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.36e-05	0.000115	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PDHA1—stomach cancer	1.36e-05	0.000115	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ECHS1—stomach cancer	1.36e-05	0.000115	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PDHA1—stomach cancer	1.35e-05	0.000114	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ECHS1—stomach cancer	1.35e-05	0.000114	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PLCE1—stomach cancer	1.33e-05	0.000112	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.33e-05	0.000112	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.32e-05	0.000112	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—MTHFR—stomach cancer	1.31e-05	0.000111	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.3e-05	0.00011	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CD44—stomach cancer	1.3e-05	0.00011	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SERPINE1—stomach cancer	1.29e-05	0.000109	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPP2R1A—stomach cancer	1.29e-05	0.000109	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.29e-05	0.000109	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMP—stomach cancer	1.28e-05	0.000108	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—FADS1—stomach cancer	1.28e-05	0.000108	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—UMPS—stomach cancer	1.27e-05	0.000108	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMP—stomach cancer	1.27e-05	0.000108	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—FADS1—stomach cancer	1.27e-05	0.000108	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.27e-05	0.000107	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.27e-05	0.000107	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTP1—stomach cancer	1.26e-05	0.000107	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.26e-05	0.000106	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—stomach cancer	1.25e-05	0.000106	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—HMOX1—stomach cancer	1.25e-05	0.000106	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RHOA—stomach cancer	1.24e-05	0.000105	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NOS3—stomach cancer	1.23e-05	0.000104	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.21e-05	0.000102	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CAV1—stomach cancer	1.2e-05	0.000102	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—APOA1—stomach cancer	1.2e-05	0.000102	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK3—stomach cancer	1.2e-05	0.000101	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SREBF2—stomach cancer	1.2e-05	0.000101	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SREBF2—stomach cancer	1.19e-05	0.000101	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.19e-05	0.0001	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PDHA1—stomach cancer	1.18e-05	0.0001	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ECHS1—stomach cancer	1.18e-05	0.0001	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RORA—stomach cancer	1.18e-05	0.0001	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RORA—stomach cancer	1.18e-05	9.95e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TYMS—stomach cancer	1.17e-05	9.95e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAU—stomach cancer	1.17e-05	9.89e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—stomach cancer	1.16e-05	9.86e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTM1—stomach cancer	1.16e-05	9.83e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.15e-05	9.74e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ERBB2—stomach cancer	1.15e-05	9.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CAV1—stomach cancer	1.14e-05	9.66e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.14e-05	9.65e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—MAPK1—stomach cancer	1.14e-05	9.64e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.14e-05	9.64e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—stomach cancer	1.14e-05	9.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—APOA1—stomach cancer	1.14e-05	9.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—BLVRB—stomach cancer	1.13e-05	9.58e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PGLS—stomach cancer	1.13e-05	9.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.12e-05	9.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—FADS1—stomach cancer	1.11e-05	9.42e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMP—stomach cancer	1.11e-05	9.42e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALDOB—stomach cancer	1.11e-05	9.38e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.1e-05	9.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALDOB—stomach cancer	1.1e-05	9.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.09e-05	9.25e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ERCC2—stomach cancer	1.09e-05	9.24e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—stomach cancer	1.09e-05	9.24e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PRKCB—stomach cancer	1.09e-05	9.19e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.08e-05	9.19e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.08e-05	9.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.08e-05	9.14e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—stomach cancer	1.08e-05	9.11e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.07e-05	9.05e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.07e-05	9.04e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.07e-05	9.02e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1B—stomach cancer	1.07e-05	9.02e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—stomach cancer	1.06e-05	8.97e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.04e-05	8.84e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SREBF2—stomach cancer	1.04e-05	8.82e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.04e-05	8.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.04e-05	8.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.04e-05	8.77e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RORA—stomach cancer	1.03e-05	8.72e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALOX5—stomach cancer	1.03e-05	8.72e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MTHFR—stomach cancer	1.03e-05	8.69e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALOX5—stomach cancer	1.02e-05	8.67e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.02e-05	8.61e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—stomach cancer	1.02e-05	8.61e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—JUN—stomach cancer	1.01e-05	8.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—DPYD—stomach cancer	1.01e-05	8.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.01e-05	8.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—DPYD—stomach cancer	1.01e-05	8.53e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TYMS—stomach cancer	1e-05	8.5e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—stomach cancer	9.93e-06	8.41e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—stomach cancer	9.88e-06	8.37e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—stomach cancer	9.87e-06	8.36e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	9.85e-06	8.34e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—stomach cancer	9.83e-06	8.33e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALDOB—stomach cancer	9.65e-06	8.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA1—stomach cancer	9.62e-06	8.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FBP1—stomach cancer	9.62e-06	8.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.62e-06	8.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CKB—stomach cancer	9.62e-06	8.15e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK8—stomach cancer	9.6e-06	8.13e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—stomach cancer	9.52e-06	8.06e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CAV1—stomach cancer	9.46e-06	8.01e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOA1—stomach cancer	9.44e-06	8e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	9.41e-06	7.97e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ERCC2—stomach cancer	9.33e-06	7.9e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	9.27e-06	7.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.18e-06	7.77e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—stomach cancer	9.14e-06	7.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.13e-06	7.73e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—NOS3—stomach cancer	9.11e-06	7.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLIN2—stomach cancer	9.05e-06	7.66e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.04e-06	7.66e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SERPINE1—stomach cancer	9.03e-06	7.65e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALOX5—stomach cancer	8.97e-06	7.59e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.97e-06	7.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—stomach cancer	8.96e-06	7.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—stomach cancer	8.91e-06	7.54e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—stomach cancer	8.86e-06	7.5e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2A6—stomach cancer	8.85e-06	7.5e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—DPYD—stomach cancer	8.82e-06	7.47e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2A6—stomach cancer	8.8e-06	7.45e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA2—stomach cancer	8.8e-06	7.45e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MTHFR—stomach cancer	8.77e-06	7.43e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—stomach cancer	8.77e-06	7.43e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—stomach cancer	8.75e-06	7.41e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RHOA—stomach cancer	8.71e-06	7.38e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	8.63e-06	7.31e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS3—stomach cancer	8.62e-06	7.3e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKR1C3—stomach cancer	8.61e-06	7.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PGAM1—stomach cancer	8.58e-06	7.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NT5E—stomach cancer	8.58e-06	7.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKR1C3—stomach cancer	8.56e-06	7.25e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO1—stomach cancer	8.39e-06	7.11e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—stomach cancer	8.38e-06	7.1e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO1—stomach cancer	8.34e-06	7.07e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—stomach cancer	8.33e-06	7.05e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—stomach cancer	8.32e-06	7.05e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.25e-06	6.99e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLCE1—stomach cancer	8.18e-06	6.93e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.18e-06	6.93e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—stomach cancer	8.15e-06	6.9e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAV1—stomach cancer	8.09e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOA1—stomach cancer	8.07e-06	6.84e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK1—stomach cancer	7.98e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—stomach cancer	7.97e-06	6.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UMPS—stomach cancer	7.84e-06	6.64e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—stomach cancer	7.8e-06	6.61e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.73e-06	6.55e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2A6—stomach cancer	7.71e-06	6.53e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—stomach cancer	7.53e-06	6.38e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1C3—stomach cancer	7.5e-06	6.35e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—stomach cancer	7.48e-06	6.33e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD44—stomach cancer	7.44e-06	6.3e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD44—stomach cancer	7.4e-06	6.27e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO1—stomach cancer	7.31e-06	6.19e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PDHA1—stomach cancer	7.29e-06	6.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ECHS1—stomach cancer	7.29e-06	6.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.22e-06	6.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.18e-06	6.08e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—stomach cancer	7.16e-06	6.06e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—stomach cancer	7.11e-06	6.02e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—stomach cancer	6.92e-06	5.86e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMP—stomach cancer	6.86e-06	5.8e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FADS1—stomach cancer	6.86e-06	5.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.84e-06	5.79e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—stomach cancer	6.7e-06	5.67e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—stomach cancer	6.55e-06	5.54e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD44—stomach cancer	6.48e-06	5.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SREBF2—stomach cancer	6.42e-06	5.44e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—stomach cancer	6.4e-06	5.42e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—stomach cancer	6.4e-06	5.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RORA—stomach cancer	6.34e-06	5.37e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPP2R1A—stomach cancer	6.33e-06	5.36e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPP2R1A—stomach cancer	6.29e-06	5.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—stomach cancer	6.21e-06	5.26e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—stomach cancer	6.21e-06	5.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—stomach cancer	6.17e-06	5.23e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—stomach cancer	6.13e-06	5.19e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HMOX1—stomach cancer	6.12e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—stomach cancer	6.12e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HMOX1—stomach cancer	6.09e-06	5.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDOB—stomach cancer	5.94e-06	5.03e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—stomach cancer	5.88e-06	4.98e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—stomach cancer	5.77e-06	4.89e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—stomach cancer	5.74e-06	4.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—stomach cancer	5.7e-06	4.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—stomach cancer	5.67e-06	4.8e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—stomach cancer	5.6e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK1—stomach cancer	5.59e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALOX5—stomach cancer	5.53e-06	4.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.51e-06	4.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DPYD—stomach cancer	5.44e-06	4.6e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—stomach cancer	5.41e-06	4.58e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—stomach cancer	5.36e-06	4.54e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HMOX1—stomach cancer	5.33e-06	4.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—stomach cancer	5.33e-06	4.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—stomach cancer	5.28e-06	4.47e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—stomach cancer	5.13e-06	4.34e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—stomach cancer	5.04e-06	4.27e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—stomach cancer	5.03e-06	4.26e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—stomach cancer	5.01e-06	4.24e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—stomach cancer	4.97e-06	4.21e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—stomach cancer	4.85e-06	4.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.81e-06	4.07e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.75e-06	4.02e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—stomach cancer	4.69e-06	3.97e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—stomach cancer	4.67e-06	3.96e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAV1—stomach cancer	4.65e-06	3.94e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOA1—stomach cancer	4.64e-06	3.93e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAV1—stomach cancer	4.62e-06	3.92e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.62e-06	3.91e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOA1—stomach cancer	4.61e-06	3.91e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO1—stomach cancer	4.5e-06	3.81e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—stomach cancer	4.49e-06	3.8e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.44e-06	3.76e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.42e-06	3.74e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—stomach cancer	4.39e-06	3.72e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—stomach cancer	4.09e-06	3.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—stomach cancer	4.07e-06	3.44e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAV1—stomach cancer	4.05e-06	3.43e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOA1—stomach cancer	4.04e-06	3.42e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—stomach cancer	4.03e-06	3.41e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD44—stomach cancer	4e-06	3.38e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—stomach cancer	3.68e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—stomach cancer	3.56e-06	3.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—stomach cancer	3.52e-06	2.98e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—stomach cancer	3.5e-06	2.96e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—stomach cancer	3.44e-06	2.92e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.4e-06	2.88e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—stomach cancer	3.33e-06	2.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMOX1—stomach cancer	3.29e-06	2.78e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—stomach cancer	3.22e-06	2.72e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—stomach cancer	3.2e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—stomach cancer	3.2e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—stomach cancer	3.1e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—stomach cancer	3.06e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—stomach cancer	3.06e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.88e-06	2.44e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—stomach cancer	2.8e-06	2.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.71e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAV1—stomach cancer	2.5e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA1—stomach cancer	2.49e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—stomach cancer	2.19e-06	1.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.98e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—stomach cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—stomach cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—stomach cancer	1.89e-06	1.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.73e-06	1.46e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—stomach cancer	1.72e-06	1.46e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.06e-06	8.99e-06	CbGpPWpGaD
